CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $507.31 | $162K | 324,723 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $508.21 | $142K | 324,443 |
| 2026-09-11 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 451,910 | ||
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $498.44 | $60K | 333,823 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,788 | $499.75 | $894K | 332,035 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,372 | $500.58 | $687K | 330,663 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,244 | $501.88 | $1.1M | 328,419 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,536 | $502.80 | $772K | 326,883 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −578 | $503.76 | $291K | 326,305 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −702 | $505.03 | $355K | 325,603 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $505.94 | $304K | 325,003 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $506.76 | $142K | 324,723 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $508.80 | $142K | 324,443 |
| 2026-09-10 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 461,410 | ||
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $493.81 | $40K | 333,863 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,202 | $495.65 | $596K | 332,661 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,278 | $496.73 | $635K | 331,383 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $497.56 | $80K | 331,223 |
Page 38 of 121 · 2,404 trades